• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因子V莱顿突变及其他影响血栓形成风险的凝血因子突变。

Factor V Leiden and other coagulation factor mutations affecting thrombotic risk.

作者信息

Bertina R M

机构信息

Hemostasis and Thrombosis Research Center, Leiden University Medical Center, The Netherlands.

出版信息

Clin Chem. 1997 Sep;43(9):1678-83.

PMID:9299960
Abstract

Five genetic defects have been established as risk factors for venous thrombosis. Three are protein C, protein S, and antithrombin deficiencies, defects in the anticoagulant pathways of blood coagulation. Together they can be found in approximately 15% of families with inherited thrombophilia. Their laboratory diagnosis is hampered by the large genetic heterogeneity of these defects. The other two genetic risk factors, resistance to activated protein C associated with the factor V Leiden mutation and increased prothrombin associated with the prothrombin 20210 A allele, are much more prevalent and together can be found in 63% of the thrombophilia families. Because both defects are caused by a single mutation, DNA analysis is the basis of their laboratory diagnosis.

摘要

五种基因缺陷已被确认为静脉血栓形成的危险因素。三种是蛋白C、蛋白S和抗凝血酶缺乏,它们是血液凝固抗凝途径中的缺陷。在遗传性血栓形成倾向的家庭中,约15%的家庭可同时发现这三种缺陷。这些缺陷的巨大基因异质性阻碍了它们的实验室诊断。另外两个基因危险因素,即与因子V Leiden突变相关的活化蛋白C抵抗和与凝血酶原20210 A等位基因相关的凝血酶原增加,更为普遍,在63%的血栓形成倾向家庭中可同时发现。由于这两种缺陷都是由单一突变引起的,DNA分析是其实验室诊断的基础。

相似文献

1
Factor V Leiden and other coagulation factor mutations affecting thrombotic risk.因子V莱顿突变及其他影响血栓形成风险的凝血因子突变。
Clin Chem. 1997 Sep;43(9):1678-83.
2
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.与遗传性易栓症相关的四种凝血缺陷中不同的血栓形成风险:一项对150个家庭的研究
Blood. 1998 Oct 1;92(7):2353-8.
3
Thrombophilia as a multigenic disease.血栓形成倾向作为一种多基因疾病。
Haematologica. 1999 Jan;84(1):59-70.
4
[Genetic risk factors of venous thromboembolism].[静脉血栓栓塞症的遗传危险因素]
Tuberk Toraks. 2003;51(1):60-9.
5
The molecular mechanisms of inherited thrombophilia.遗传性血栓形成倾向的分子机制。
Z Kardiol. 2000 Jul;89(7):575-86. doi: 10.1007/s003920070206.
6
Activated protein C resistance--a major risk factor for thrombosis.活化蛋白C抵抗——血栓形成的主要危险因素。
Eur J Clin Chem Clin Biochem. 1997 Jul;35(7):501-16.
7
Hereditary thrombophilia and venous thromboembolism.遗传性血栓形成倾向与静脉血栓栓塞症
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1369-73. doi: 10.1164/ajrccm.158.5.9712022.
8
Familial thrombophilia: a complex genetic disorder.家族性血栓形成倾向:一种复杂的遗传疾病。
Semin Hematol. 1997 Jul;34(3):256-64.
9
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.凝血酶原G20210A变异体和因子V莱顿突变携带者发生静脉血栓形成的风险及其与口服避孕药的相互作用。
Haematologica. 2000 Dec;85(12):1271-6.
10
High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan.台湾静脉血栓形成倾向的中国患者中抗凝血酶III、蛋白C和蛋白S缺乏症的高患病率,但无因子V莱顿突变。
Thromb Res. 1997 Aug 15;87(4):377-85. doi: 10.1016/s0049-3848(97)00141-2.

引用本文的文献

1
Testing for Factor V Leiden (FVL) and Prothrombin G20210A Genetic Variants.检测因子 V 莱顿(FVL)和凝血酶原 G20210A 基因突变。
Methods Mol Biol. 2023;2663:233-251. doi: 10.1007/978-1-0716-3175-1_14.
2
PlA2 Polymorphism of Platelet Glycoprotein IIb/IIIa and C677T Polymorphism of Methylenetetrahydrofolate Reductase (), but Not Factor V Leiden and Prothrombin G20210A Polymorphisms, Are Associated with More Severe Forms of Legg-Calvé-Perthes Disease.血小板糖蛋白IIb/IIIa的磷脂酶A2多态性和亚甲基四氢叶酸还原酶的C677T多态性(而非因子V莱顿突变和凝血酶原G20210A多态性)与更严重形式的Legg-Calvé-Perthes病相关。
Children (Basel). 2021 Jul 20;8(7):614. doi: 10.3390/children8070614.
3
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.
长期新冠或新冠后急性后遗症(PASC):可能导致持续症状的生物学因素概述
Front Microbiol. 2021 Jun 23;12:698169. doi: 10.3389/fmicb.2021.698169. eCollection 2021.
4
The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk.遗传风险因素与不同类型复方口服避孕药联合应用对静脉血栓栓塞风险的联合效应。
Br J Haematol. 2020 Oct;191(1):90-97. doi: 10.1111/bjh.16666. Epub 2020 Apr 27.
5
Residues W215, E217 and E192 control the allosteric E*-E equilibrium of thrombin.残基 W215、E217 和 E192 控制凝血酶的变构 E*-E 平衡。
Sci Rep. 2019 Aug 23;9(1):12304. doi: 10.1038/s41598-019-48839-1.
6
Influence of tissue factor polymorphisms (603A>G and 5466A>G) on plasma tissue factor levels and their impact on deep vein thrombosis risk in young Indian population.组织因子多态性(603A>G 和 5466A>G)对血浆组织因子水平的影响及其对印度年轻人群深静脉血栓形成风险的影响。
J Thromb Thrombolysis. 2018 Jul;46(1):88-94. doi: 10.1007/s11239-018-1666-6.
7
Is there a link among thrombophilia factors and preeclampsia?血栓形成倾向因素与子痫前期之间存在关联吗?
J Thromb Thrombolysis. 2017 Nov;44(4):516-518. doi: 10.1007/s11239-017-1556-3.
8
Prevalence of thrombophilic mutations in patients with unprovoked thromboembolic disease. A comparative analysis regarding arterial and venous disease.不明原因血栓栓塞性疾病患者中血栓形成倾向突变的患病率。关于动脉和静脉疾病的比较分析。
Hippokratia. 2012 Jul;16(3):250-5.
9
Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region.《地中海地区凝血酶原 G20210A 突变的流行病学》
Mediterr J Hematol Infect Dis. 2011;3(1):e2011054. doi: 10.4084/MJHID.2011.054. Epub 2011 Nov 28.
10
Inherited trombophilic states and pulmonary embolism.遗传性易栓症与肺栓塞。
J Res Med Sci. 2009 Jan;14(1):43-56.